2024-11-15 2025-11-30 false Capium Accounts Production 1.1 16082154 2024-11-15 2025-11-30 16082154 bus:AbridgedAccounts 2024-11-15 2025-11-30 16082154 bus:FRS102 2024-11-15 2025-11-30 16082154 bus:AuditExemptWithAccountantsReport 2024-11-15 2025-11-30 16082154 bus:SmallCompaniesRegimeForAccounts 2024-11-15 2025-11-30 16082154 bus:PrivateLimitedCompanyLtd 2024-11-15 2025-11-30 16082154 2024-11-15 2025-11-30 16082154 2025-11-30 16082154 bus:RegisteredOffice 2024-11-15 2025-11-30 16082154 core:WithinOneYear 2025-11-30 16082154 core:AfterOneYear 2025-11-30 16082154 1 2024-11-15 2025-11-30 16082154 bus:Director1 2024-11-15 2025-11-30 16082154 bus:Director1 2025-11-30 16082154 bus:Director2 2024-11-15 2025-11-30 16082154 bus:Director2 2025-11-30 16082154 2023-11-15 16082154 bus:LeadAgentIfApplicable 2024-11-15 2025-11-30 16082154 2024-11-14 16082154 bus:OrdinaryShareClass1 2024-11-15 2025-11-30 16082154 bus:OrdinaryShareClass1 2025-11-30 16082154 core:CostValuation core:Non-currentFinancialInstruments 2025-11-30 16082154 core:CostValuation core:Non-currentFinancialInstruments 2024-11-14 16082154 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-11-30 16082154 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 16082154 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 16082154 core:Non-currentFinancialInstruments 2025-11-30 16082154 core:Non-currentFinancialInstruments 2024-11-14 16082154 core:ShareCapital 2025-11-30 16082154 core:RetainedEarningsAccumulatedLosses 2025-11-30 16082154 dpl:Item1 2024-11-15 16082154 dpl:Item1 2025-11-30 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 16082154
England and Wales
ABOUZID RADIOLOGY LTD
Abridged Accounts
Period of accounts Start date: 15 November 2024 End date: 30 November 2025

Abouzid Radiology Ltd Contents Page For the Period 15 November 2024 to 30 November 2025
Accountants' report | 1
Statement of financial position | 2
Notes to the financial statements | 3

Abouzid Radiology Ltd Accountants' Report For the Period 15 November 2024 to 30 November 2025
Accountants report You consider that the company is exempt from an audit for the year ended 30 November 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Balance Sheet and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. .................................................... Akhter's Limited Accountants and Business Advisors 64 Castle Boulevard Nottingham NG7 1FN 12 January 2026 1

Abouzid Radiology Ltd Statement of Financial Position As at 30 November 2025
| Notes | 2025 £
--- | --- | ---
Current assets |  |
Cash at bank and in hand |  | 8,587
Creditors: amount falling due within one year |  | (5,889)
Net current assets |  | 2,698
Total assets less current liabilities |  | 2,698
Creditors: amount falling due after more than one year |  | (317)
Net assets |  | 2,381
Capital and reserves |  |
Called up share capital | 3 | 200
Profit and loss account |  | 2,181
Shareholders' funds |  | 2,381
For the period ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Directors' responsibilities: The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the profit and loss account has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the board of directors on 12 January 2026 and were signed on its behalf by:
------------------------------- Dr Islam Aly Abdelgawad Mohamed Aly Abouzid Director
2

Abouzid Radiology Ltd Notes to the Abridged Financial Statements For the Period 15 November 2024 to 30 November 2025
General Information Abouzid Radiology Ltd is a private company, limited by shares, registered in England and Wales, registration number 16082154, registration address 64 Castle Boulevard, Nottingham, NG7 1FN. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard) Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of trade discounts. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted
2. | Average number of employees Average number of employees during the period was 2.
3. | Share Capital
Allotted, called up and fully paid | 2025 £
--- | ---
200 Ordinary shares of £1.00 each | 200
| 200
3